2-[1,12-dibromo-12-(3-methyl-1H-imidazol-3-ium-2-yl)dodecyl]-3-methyl-1H-imidazol-3-ium
C20H34Br2N4+2 — CID 90765057
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[1,12-dibromo-12-(3-methyl-1H-imidazol-3-ium-2-yl)dodecyl]-3-methyl-1H-imidazol-3-ium
2-[1,12-dibromo-12-(3-methyl-1H-imidazol-3-ium-2-yl)dodecyl]-3-methyl-1H-imidazol-3-ium (PubChem CID 90765057) has the molecular formula C20H34Br2N4+2 and a molecular weight of 490.33 g/mol. Its IUPAC name is 2-[1,12-dibromo-12-(3-methyl-1H-imidazol-3-ium-2-yl)dodecyl]-3-methyl-1H-imidazol-3-ium.
Molecular Properties
| Compound Name | 2-[1,12-dibromo-12-(3-methyl-1H-imidazol-3-ium-2-yl)dodecyl]-3-methyl-1H-imidazol-3-ium |
|---|---|
| PubChem CID | 90765057 |
| Molecular Formula | C20H34Br2N4+2 |
| Molecular Weight | 490.33 g/mol |
| Exact Mass | 488.11 |
| IUPAC Name | 2-[1,12-dibromo-12-(3-methyl-1H-imidazol-3-ium-2-yl)dodecyl]-3-methyl-1H-imidazol-3-ium |
| SMILES | C[n+]1cc[nH]c1C(Br)CCCCCCCCCCC(Br)c1[nH]cc[n+]1C |
| InChI | InChI=1S/C20H32Br2N4/c1-25-15-13-23-19(25)17(21)11-9-7-5-3-4-6-8-10-12-18(22)20-24-14-16-26(20)2/h13-18H,3-12H2,1-2H3/p+2 |
| InChIKey | UKGRANXISKMMOL-UHFFFAOYSA-P |
| XLogP | 5.47 |
| TPSA | 39.34 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | |
| Rotatable Bonds | 13 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 490.33 |
| LogP ≤ 5 | 5.47 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 0 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'alkyl_halide', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 90765057 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.